The Basil Hetzel Institute for Translational Health Research (BHI) is the productive research arm of The Queen Elizabeth Hospital and home to almost 200 researchers and research administrative staff.

The BHI provides a dynamic, state-of-the-art research environment for vital ‘bench to bedside’ research and research training opportunities. Affiliated with the University of Adelaide, Flinders University and the University of South Australia, the BHI is a short walk from The Queen Elizabeth Hospital, allowing for a vital and active interface between researchers and clinicians.

All research groups have strong links to clinical divisions within the Hospital underpinning The Institute’s overarching focus on translational health research. This ‘bench to bedside’ approach is at the forefront of an emerging area of medical science that aims to improve public health through collaborative discoveries and innovations in patient care, education and research.

Research conducted by The Institute covers a broad spectrum, exploring causes, potential improvements in therapeutic outcomes and the prevention of some of the most serious and common health conditions facing our community today.

Research areas include;

  • Ageing
  • Cancer – breast cancer, colorectal (bowel) cancer, liver metastasis, prostate and oesophageal cancer
  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Sciences, Health services and Population Health
  • Drug and Vaccine Development
  • Inflammatory Disease


The Basil Hetzel Institute for Translational Health Research is home to almost 200 researchers and administrative staff.

Opened in 2009, the facility was proudly named after the first Professor of Medicine at the hospital and one of Australia’s leading medical researchers, the late Honourable Basil Hetzel AC. Revered world-wide for his pioneering work which discovered the link between iodized salt in the diet and the prevention of brain damage in newborns, Dr Hetzel’s groundbreaking research has helped millions of children in 130 countries where iodine is lacking.

His passion and drive to prevent brain damaged babies born as a result of iodine deficiency around the world has been recognized as one of the most significant medical discoveries of modern times.

Dr Hetzel has received numerous academic and humanitarian awards, not only for his landmark medical research but for his commitment, vision and leadership in the areas of public and community health.

His strong support for the translational medical research undertaken at the facility which proudly bears his name continues to inspire current researchers and those yet to make their mark in the field.

support the basil hetzel institute

learn more about how you are making an impact

Travelling and Connecting with World-Class Researchers

Researchers Professor Eric Gowans and Dr Danushka Wijesundara from the Virology team at the Basil Hetzel Institute for Translational Health Research both recently attended national and international conferences thanks to The Hospital Research Foundation (THRF). read more

New Research Set to Save Lives at TQEH

The Hospital Research Foundation (THRF) is delighted to announce the recipients in its 2018 Grant Round at The Queen Elizabeth Hospital and its research arm, the Basil Hetzel Institute for Translational Health Research. read more

A Conference Filled with Invaluable Experience

Thanks to the support of The Hospital Research Foundation’s (THRF) valued donors, cancer researchers Dr Bill Panagopoulos and PhD student Alex Shoubridge from the Basil Hetzel Institute for Translational Health Research (BHI) attended a world-leading bone conference in the Clare Valley. read more

Connecting with World-Class Researchers across the Globe

The Hospital Research Foundation (THRF) recently supported researchers Dr Eric Smith and Dr Helen Palethorpe from The Basil Hetzel Institute for Translational Health Research to attend the highly regarded Lorne Cancer Conference, bringing together world-class cancer researchers from across the globe. read more